Clinical trials
Completed Observational Pseudomonas Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| CF Therapeutics Development Network Coordinating Center | 1 |
| Central Hospital, Nancy, France | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| Erasmus Medical Center | 1 |
| Gilead Sciences | 1 |
| Indiana University | 1 |
| Landon Pediatric Foundation | 1 |
| Maimonides Medical Center | 1 |
| T2 Biosystems | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pseudomonas Infections | 18 |
| Cystic Fibrosis | 10 |
| COVID-19 | 2 |
| Asymptomatic Infections | 1 |
| Bacteremia | 1 |
| Bacterial Infections | 1 |
| Cross Infection | 1 |
| Disease | 1 |
| Gram-Negative Bacterial Infections | 1 |
| Immunologic Deficiency Syndromes | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.